The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5117314 6102089 F 5117314-2 20060710 20060731 20060929 EXP PHEH2006US09891 NOVARTIS PHARMACEUTICALS CORP. 28 YR M Y 74.829 KG 20060929 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5117314 1007715812 PS EXJADE 1 ORAL 1500 MG, QD 21882
5117314 1007715813 C HYDREA 1 1000 MG, QD
5117314 1007715814 C FOLIC ACID 1 1 MG, QD

Indications of drugs used

Event ID DRUG SEQ INDI PT
5117314 1007715813 SICKLE CELL ANAEMIA
5117314 1007715814 SICKLE CELL ANAEMIA

Outcome of event

Event ID OUTC COD
5117314 HO

Reactions reported

Event ID PT
5117314 ALANINE AMINOTRANSFERASE INCREASED
5117314 ASPARTATE AMINOTRANSFERASE INCREASED
5117314 BLOOD ALKALINE PHOSPHATASE INCREASED
5117314 BLOOD BILIRUBIN INCREASED
5117314 BLOOD LACTATE DEHYDROGENASE INCREASED
5117314 CHOLELITHIASIS
5117314 CHOLESTASIS
5117314 CHROMATURIA
5117314 HEPATITIS CHOLESTATIC
5117314 JAUNDICE

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5117314 1007715812 20060320 20060715 118 DAY